Chemotherapy versus Hypomethylating Agents for the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell Transplant
详细信息 查看全文
- 作者：Ibraheem H. Motabi1 ; 2 ; Armin Ghobadi1 ; Jingxia Liu3 ; Mark Schroeder1 ; Camille N. Abboud1 ; Amanda F. Cashen1 ; Keith E. Stockler-Goldstein1 ; Geoffrey L. Uy1 ; Ravi Vij1 ; Peter Westervelt1 ; John F. DiPersio1 ; jdipersi@dom.wustl.edu" class="auth_mail" title="E-mail the corresponding author
- 关键词：Allogeneic stem cell transplant ; AML ; MDS ; DLI ; Chemotherapy ; Hypomethylating agents
- 刊名：Biology of Blood and Marrow Transplantation
- 出版年：2016
- 出版时间：July 2016
- 年：2016
- 卷：22
- 期：7
- 页码：1324-1329
- 全文大小：359 K
文摘
- •
Chemotherapy was compared with HAs for relapsed AML and MDS after allo-SCT.
- •
Chemotherapy compared with HAs resulted in a better ORR.
- •
Chemotherapy followed by DLI resulted in a superior rate of 1-year OS (44%).